b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="In-Process" Owner="NLM">\n        <PMID Version="1">31263993</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>04</Month>\n            <Day>16</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1437-160X</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>40</Volume>\n                    <Issue>1</Issue>\n                    <PubDate>\n                        <Year>2020</Year>\n                        <Month>Jan</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Rheumatology international</Title>\n                <ISOAbbreviation>Rheumatol. Int.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Prescribing motivations and patients\' characteristics related to the use of biologic drugs in adult-onset Still\'s disease: analysis of a multicentre &quot;real-life&quot; cohort.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>107-113</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00296-019-04358-w</ELocationID>\n            <Abstract>\n                <AbstractText>A growing body of evidence suggests the usability of biologic disease-modifying anti-rheumatic drugs (bDMARDs) in treating adult-onset Still\'s disease (AOSD). In a multicentre &quot;real-life&quot; cohort, the physicians\' prescribing motivations and patients\' predictive characteristics of being treated with bDMARDs were assessed. Patients with AOSD, who were included in GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) cohort and treated with bDMARDs, were retrospectively assessed. Relevant data were collected by a review of clinical charts. Forty-four patients treated with bDMARDs were analysed, with slight male preponderance (52.3%) and a mean age of 39.3\xe2\x80\x89\xc2\xb1\xe2\x80\x8915.2\xc2\xa0years. All patients were treated with corticosteroids (CCSs) (38.6% with low dosage) and 93.2% were treated with synthetic DMARDs (sDMARDs). Regarding the effectiveness of the first-line bDMARD, 65.6% of patients experienced a complete remission, defined as complete disappearance of both systemic and joint symptoms and normalisation of laboratory evidence of disease. The physicians\' prescribing motivations for bDMARDs were inadequate response to CCSs and/or sDMARDs, CCS-sparing effect and occurrence of macrophage activation syndrome (MAS). Analysing patients\' characteristics, chronic disease course (OR 3.09; 95%CI 1.22-7.80, p\xe2\x80\x89=\xe2\x80\x890.017), defined as disease with persistent symptoms, was predictive of being treated with bDMARDs, whereas age (OR 0.97, 95%CI 0.93-0.99, p\xe2\x80\x89=\xe2\x80\x890.048) was negatively associated, suggesting younger age as a further predictive factor. Patients with AOSD were treated with bDMARDs for inadequate response to CCSs and/or sDMARDs, CCS-sparing effect and MAS occurrence. Younger age and chronic disease course were patients\' predictive characteristics of being treated with bDMARDs.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Ruscitti</LastName>\n                    <ForeName>Piero</ForeName>\n                    <Initials>P</Initials>\n                    <Identifier Source="ORCID">http://orcid.org/0000-0003-3487-8551</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L\'Aquila, Delta 6 Building, PO box 67100, L\'Aquila, Italy. piero.ruscitti@univaq.it.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Cipriani</LastName>\n                    <ForeName>Paola</ForeName>\n                    <Initials>P</Initials>\n                    <Identifier Source="ORCID">http://orcid.org/0000-0002-2000-4661</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L\'Aquila, Delta 6 Building, PO box 67100, L\'Aquila, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Liakouli</LastName>\n                    <ForeName>Vasiliki</ForeName>\n                    <Initials>V</Initials>\n                    <Identifier Source="ORCID">http://orcid.org/0000-0002-7392-9334</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L\'Aquila, Delta 6 Building, PO box 67100, L\'Aquila, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Iacono</LastName>\n                    <ForeName>Daniela</ForeName>\n                    <Initials>D</Initials>\n                    <Identifier Source="ORCID">http://orcid.org/0000-0002-3105-6096</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Clinical and Experimental Medicine, Rheumatology Section, University of Campania &quot;Luigi Vanvitelli&quot;, Naples, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Pantano</LastName>\n                    <ForeName>Ilenia</ForeName>\n                    <Initials>I</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Clinical and Experimental Medicine, Rheumatology Section, University of Campania &quot;Luigi Vanvitelli&quot;, Naples, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Caso</LastName>\n                    <ForeName>Francesco</ForeName>\n                    <Initials>F</Initials>\n                    <Identifier Source="ORCID">http://orcid.org/0000-0002-8928-2520</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Rheumatology Unit, Department of Clinical Medicine and Surgery, School of Medicine, University of Naples Federico II, Naples, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Perosa</LastName>\n                    <ForeName>Federico</ForeName>\n                    <Initials>F</Initials>\n                    <Identifier Source="ORCID">http://orcid.org/0000-0002-4072-4244</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Rheumatologic and Systemic Autoimmune Diseases Unit, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari Medical School, Bari, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Atzeni</LastName>\n                    <ForeName>Fabiola</ForeName>\n                    <Initials>F</Initials>\n                    <Identifier Source="ORCID">http://orcid.org/0000-0002-9328-3075</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Cantatore</LastName>\n                    <ForeName>Francesco Paolo</ForeName>\n                    <Initials>FP</Initials>\n                    <Identifier Source="ORCID">http://orcid.org/0000-0001-9929-9177</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Rheumatology Unit, Department of Medical and Surgery Sciences, University of Foggia, Foggia, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Scarpa</LastName>\n                    <ForeName>Raffaele</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Rheumatology Unit, Department of Clinical Medicine and Surgery, School of Medicine, University of Naples Federico II, Naples, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ciccia</LastName>\n                    <ForeName>Francesco</ForeName>\n                    <Initials>F</Initials>\n                    <Identifier Source="ORCID">http://orcid.org/0000-0002-9352-1264</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Clinical and Experimental Medicine, Rheumatology Section, University of Campania &quot;Luigi Vanvitelli&quot;, Naples, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Giacomelli</LastName>\n                    <ForeName>Roberto</ForeName>\n                    <Initials>R</Initials>\n                    <Identifier Source="ORCID">http://orcid.org/0000-0003-0670-9638</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L\'Aquila, Delta 6 Building, PO box 67100, L\'Aquila, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>07</Month>\n                <Day>01</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Germany</Country>\n            <MedlineTA>Rheumatol Int</MedlineTA>\n            <NlmUniqueID>8206885</NlmUniqueID>\n            <ISSNLinking>0172-8172</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Adult-onset Still\xe2\x80\x99s disease</Keyword>\n            <Keyword MajorTopicYN="N">Anakinra</Keyword>\n            <Keyword MajorTopicYN="N">Biologic drugs</Keyword>\n            <Keyword MajorTopicYN="N">Tocilizumab</Keyword>\n            <Keyword MajorTopicYN="N">Tumour necrosis factor inhibitor</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>04</Month>\n                <Day>27</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>06</Month>\n                <Day>22</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>7</Month>\n                <Day>3</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>7</Month>\n                <Day>3</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>7</Month>\n                <Day>3</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31263993</ArticleId>\n            <ArticleId IdType="doi">10.1007/s00296-019-04358-w</ArticleId>\n            <ArticleId IdType="pii">10.1007/s00296-019-04358-w</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Clin Rheumatol. 2014 Jan;33(1):49-55</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24005839</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Medicine (Baltimore). 2019 Apr;98(15):e15123</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30985672</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Rheumatol. 2017 Dec;36(12):2839-2845</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28914368</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ther Clin Risk Manag. 2014 Dec 22;11:33-43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25653531</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Rheumatol. 2016 Jul;35(7):1683-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27207567</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>JAMA. 2004 Jun 2;291(21):2616-22</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15173153</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Front Pharmacol. 2017 Jun 13;8:369</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28659802</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Autoimmun. 2018 Sep;93:24-36</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30077425</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Eval Clin Pract. 2010 Apr;16(2):284-91</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20367849</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Rheumatol Int. 2012 May;32(5):1291-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21274538</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Autoimmun Rev. 2014 Jul;13(7):708-22</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24657513</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Rheumatol. 2018 Jun;45(6):864-872</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29657144</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Eval Clin Pract. 2011 Aug;17(4):621-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20973873</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arthritis Rheum. 1987 Feb;30(2):186-94</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">3827959</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Crit Care Med. 2016 Feb;44(2):275-81</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26584195</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mod Rheumatol. 2011 Feb;21(1):92-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20737186</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Rheumatol. 2009 May;36(5):1026-31</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19273456</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>BMC Med. 2016 Dec 1;14(1):194</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27903264</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Rheumatol. 2014 Mar;33(3):305-14</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24435354</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Autoimmun Rev. 2014 Nov;13(11):1149-59</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25183244</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Rheumatol. 1992 Mar;19(3):424-30</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">1578458</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Expert Rev Clin Immunol. 2017 Nov;13(11):1041-1047</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28837367</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Autoimmun Rev. 2017 Jan;16(1):16-21</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27664384</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Expert Rev Clin Immunol. 2017 Nov;13(11):1089-1097</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28870100</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Expert Rev Clin Immunol. 2018 Nov;14(11):965-976</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30295095</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'